Therapeutic product effect decreased: FDA reporting patterns
43,799 FDA FAERS reports mention Therapeutic product effect decreased. 22,128 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 12,106 reports
- Etanercept: 9,866 reports
- Methotrexate: 9,239 reports
- Abatacept: 7,524 reports
- Tocilizumab: 7,494 reports
- Leflunomide: 7,350 reports
- Infliximab: 6,921 reports
- Hydroxychloroquine: 6,768 reports
- Rituximab: 6,676 reports
- Golimumab: 5,706 reports
- Sulfasalazine: 5,628 reports
- Certolizumab Pegol: 5,579 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.